Pierre-François Plouin
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Pierre-François Plouin has a total of 229 co-authors. Here are the top co-authors by number of shared publications:
- Laurence Amar
Hypertension Unit, AP-HP, Hôpital Européen Georges Pompidou, Paris, France (L.A., B.P.).
11 shared publications - Anne-Paule Gimenez-Roqueplo
Université Paris Cité, PARCC, INSERM, Paris, France
7 shared publications - Olivier Steichen
Sorbonne Université, INSERM, Sorbonne Public Health Institute (SPH), Paris, France
5 shared publications Aurélien Lorthioir
3 shared publicationsAlessandra Giavarini
2 shared publicationsGuillaume Bobrie
2 shared publications
Latest Publications
- 1 July 2016
- Published by Elsevier in Annales d'Endocrinologie
- Vol. 77 (3) , 208-213
SFE/SFHTA/AFCE consensus on primary aldosteronism, part 4: Subtype diagnosis
- 1 July 2016
- Published by Elsevier in Annales d'Endocrinologie
- Vol. 77 (3) , 208-213
SFE/SFHTA/AFCE consensus on primary aldosteronism, part 4: Subtype diagnosis
- 1 September 2015
- Published by The Endocrine Society in The Journal of Clinical Endocrinology & Metabolism
- Vol. 100 (9) , 3297-3303
Deciphering the Role of Vasopressin in Primary Aldosteronism
The role of vasopressin (AVP) in the pathophysiology of primary aldosteronism (PA) remains unclear. 1) Primary: To investigate AVP secretion in PA by measuring the plasma concentration of copeptin (PCop), the C-terminal portion of provasopressin; 2) secondary: to assess renal sensitivity to AVP. Cross-sectional study Tertiary-care hospital. We recruited 115 patients with PA, 48 patients with essential hypertension (EH), and 108 normotensive healthy subjects (HS). Blood was sampled in fasting condition after 1-hour rest in supine position, for biochemical and hormonal evaluations. Osmolality was determined in 24 h urine. PCop was determined by immunoassay. Adjusted difference in PCop between groups. After adjustment for sex, body mass index, systolic blood pressure, natremia and kalemia, PCop was significantly higher in PA patients than in HS (geometric mean ratio: 1.61 [95% CI: 1.26; 2.06], P < 0.0001) and EH patients (1.40 [95% CI: 1.08; 1.82], P = 0.0070 PCop was positively correlated with natremia (P = 0.0094). Urine osmolality was significantly lower in PA patients than in HS (0.82 [0.74; 0.92], P = 0.0002) and 24-hour urinary output was significantly higher in PA patients than in HS (1.32 [1.11; 1.56], P = 0.0005). The relationship between urine osmolality and PCop was shifted downwards in PA patients but was similar in EH patients and HS, indicating peripheral resistance to AVP. PCop increases in patients with PA, in response to an increase in natremia and a renal resistance phenomenon, indicating that AVP release is chronically stimulated in PA.
- 1 September 2015
- Published by The Endocrine Society in The Journal of Clinical Endocrinology & Metabolism
- Vol. 100 (9) , 3297-3303
Deciphering the Role of Vasopressin in Primary Aldosteronism
The role of vasopressin (AVP) in the pathophysiology of primary aldosteronism (PA) remains unclear. 1) Primary: To investigate AVP secretion in PA by measuring the plasma concentration of copeptin (PCop), the C-terminal portion of provasopressin; 2) secondary: to assess renal sensitivity to AVP. Cross-sectional study Tertiary-care hospital. We recruited 115 patients with PA, 48 patients with essential hypertension (EH), and 108 normotensive healthy subjects (HS). Blood was sampled in fasting condition after 1-hour rest in supine position, for biochemical and hormonal evaluations. Osmolality was determined in 24 h urine. PCop was determined by immunoassay. Adjusted difference in PCop between groups. After adjustment for sex, body mass index, systolic blood pressure, natremia and kalemia, PCop was significantly higher in PA patients than in HS (geometric mean ratio: 1.61 [95% CI: 1.26; 2.06], P < 0.0001) and EH patients (1.40 [95% CI: 1.08; 1.82], P = 0.0070 PCop was positively correlated with natremia (P = 0.0094). Urine osmolality was significantly lower in PA patients than in HS (0.82 [0.74; 0.92], P = 0.0002) and 24-hour urinary output was significantly higher in PA patients than in HS (1.32 [1.11; 1.56], P = 0.0005). The relationship between urine osmolality and PCop was shifted downwards in PA patients but was similar in EH patients and HS, indicating peripheral resistance to AVP. PCop increases in patients with PA, in response to an increase in natremia and a renal resistance phenomenon, indicating that AVP release is chronically stimulated in PA.
- 1 March 2015
- Published by Oxford University Press (OUP) in European Journal of Endocrinology
- Vol. 172 (3) , R125-R129
PROGRESS IN PRIMARY ALDOSTERONISM: Mineralocorticoid antagonist treatment for aldosterone-producing adenoma
Mineralocorticoid receptor antagonists have been used in patients with aldosterone-producing adenomas (APAs) as a test designed to predict the blood pressure (BP) outcome of surgery. They are commonly used in patients undergoing adrenalectomy to reduce BP and increase plasma potassium levels during the preoperative period. A small number of studies have compared the effects of surgery and mineralocorticoid antagonists either on BP, on serum potassium levels, or on the incidence of cardiovascular and renal outcomes in patients with primary aldosteronism with or without an APA; these studies found no difference between the two therapeutic options. Mineralocorticoid receptor antagonists can be used as a maintenance treatment for patients with APAs, who are judged to be poor operative risks or who do not want to undergo surgery.
- 1 March 2015
- Published by Oxford University Press (OUP) in European Journal of Endocrinology
- Vol. 172 (3) , R125-R129
PROGRESS IN PRIMARY ALDOSTERONISM: Mineralocorticoid antagonist treatment for aldosterone-producing adenoma
Mineralocorticoid receptor antagonists have been used in patients with aldosterone-producing adenomas (APAs) as a test designed to predict the blood pressure (BP) outcome of surgery. They are commonly used in patients undergoing adrenalectomy to reduce BP and increase plasma potassium levels during the preoperative period. A small number of studies have compared the effects of surgery and mineralocorticoid antagonists either on BP, on serum potassium levels, or on the incidence of cardiovascular and renal outcomes in patients with primary aldosteronism with or without an APA; these studies found no difference between the two therapeutic options. Mineralocorticoid receptor antagonists can be used as a maintenance treatment for patients with APAs, who are judged to be poor operative risks or who do not want to undergo surgery.
- 1 January 2015
- Vol. 210, 887-91
A "pivot" Model to set up Large Scale Rare Diseases Information Systems: Application to the Fibromuscular Dysplasia Registry.
The SIR-FMD project is a partnership between the Department of Genetics and Reference Centre for Rare Vascular Diseases at the Georges Pompidou European Hospital in Paris and the Medical Informatics and Knowledge Engineering Laboratory of Inserm. Its aim is to use an ontological approach to implement an information system for the French Fibromuscular Dysplasia Registry. The existing data was dispersed in numerous databases, which had been created independently. These databases have different structures and contain data of diverse quality. The project aims to provide generic solutions for the management of the communication of medical data. The secondary objective is to demonstrate the applicability of these generic solutions in the field of rare diseases (RD) in an operational context. The construction of the French FMD registry was a multistep process. A secure platform has been available since the beginning of November 2013. The medical records of 471 patients from the initial dataset provided by the HEGP-Paris, France have been included, and are accessible from a secure user account. Users are organized into a collaborative group, and can access patient groups. Each electronic patient record contains more than 2,200 items. The problem of semantic interoperability has become one of the major challenges for the development of applications requiring the sharing and reuse of data. The information system component of the SIR-FMD project has a direct impact on the standardisation of coding of rare diseases and thereby contributes to the development of e-Health.
- 1 January 2015
- Vol. 210, 887-91
A "pivot" Model to set up Large Scale Rare Diseases Information Systems: Application to the Fibromuscular Dysplasia Registry.
The SIR-FMD project is a partnership between the Department of Genetics and Reference Centre for Rare Vascular Diseases at the Georges Pompidou European Hospital in Paris and the Medical Informatics and Knowledge Engineering Laboratory of Inserm. Its aim is to use an ontological approach to implement an information system for the French Fibromuscular Dysplasia Registry. The existing data was dispersed in numerous databases, which had been created independently. These databases have different structures and contain data of diverse quality. The project aims to provide generic solutions for the management of the communication of medical data. The secondary objective is to demonstrate the applicability of these generic solutions in the field of rare diseases (RD) in an operational context. The construction of the French FMD registry was a multistep process. A secure platform has been available since the beginning of November 2013. The medical records of 471 patients from the initial dataset provided by the HEGP-Paris, France have been included, and are accessible from a secure user account. Users are organized into a collaborative group, and can access patient groups. Each electronic patient record contains more than 2,200 items. The problem of semantic interoperability has become one of the major challenges for the development of applications requiring the sharing and reuse of data. The information system component of the SIR-FMD project has a direct impact on the standardisation of coding of rare diseases and thereby contributes to the development of e-Health.
- 1 November 2014
- Published by Elsevier in La Revue de Médecine Interne
- Vol. 35 (11) , 697-699
Dilatation des sténoses athéroscléreuses des artères rénales : la fin de l’histoire ?
- 1 November 2014
- Published by Elsevier in La Revue de Médecine Interne
- Vol. 35 (11) , 697-699
Dilatation des sténoses athéroscléreuses des artères rénales : la fin de l’histoire ?
- 17 April 2014
- Published by Bioscientifica in Endocrine Abstracts
The influence of diagnostic criteria on the interpretation of adrenal venous sampling
Objective: Recent guidelines promote adrenal venous sampling (AVS) as the reference test to document lateralised aldosterone hypersecretion in primary aldosteronism (PA). However, there are wide discrepancies between institutions in the criteria used. Our objective was to evaluate their consequences on the interpretation of AVS results. Design and methods: All 506 AVS performed from 01/2001 to 03/2009 in our institution were included. Results were interpreted using the criteria reported in papers from four experienced institutions where Cosyntropin is not infused during AVS (Brisbane, Padua, Paris, and Turin). AVS were classified as: i) unsuccessful if they did not meet the criterion of selectivity; ii) left or iii) right if successful and meeting the lateralisation criterion on the considered side; iv) bilateral otherwise. When multiple samples were available from at least one side, we compared the classification induced by the two most extreme lateralisation ratios from all possible combinations of right and left selective samples. Results: The proportion of AVS classified as unsuccessful was almost five times higher with the strictest criteria than with the least strict (18 vs 4%). The proportion of AVS classified as lateralised was more than twice higher with the least stringent criteria than with the most stringent (60 vs 26%). Multiple samples where available from at least one side in 147 AVS. Patients with more than one selective sample were classified differently with the two most extreme samples combinations in 16% (Brisbane) to 18% (Padua) of cases (Fisher’s P=0.75). Conclusion: Different sets of criteria currently used in experienced institutions translate into extremely heterogeneous classifications, and hence surgical decisions, for PA patients. AVS cannot be regarded as a gold standard until the most appropriate procedure and diagnostic criteria have been defined. Large and well-designed studies, preferably multicentre, are needed to resolve this issue.
- 17 April 2014
- Published by Bioscientifica in Endocrine Abstracts
The influence of diagnostic criteria on the interpretation of adrenal venous sampling
Objective: Recent guidelines promote adrenal venous sampling (AVS) as the reference test to document lateralised aldosterone hypersecretion in primary aldosteronism (PA). However, there are wide discrepancies between institutions in the criteria used. Our objective was to evaluate their consequences on the interpretation of AVS results. Design and methods: All 506 AVS performed from 01/2001 to 03/2009 in our institution were included. Results were interpreted using the criteria reported in papers from four experienced institutions where Cosyntropin is not infused during AVS (Brisbane, Padua, Paris, and Turin). AVS were classified as: i) unsuccessful if they did not meet the criterion of selectivity; ii) left or iii) right if successful and meeting the lateralisation criterion on the considered side; iv) bilateral otherwise. When multiple samples were available from at least one side, we compared the classification induced by the two most extreme lateralisation ratios from all possible combinations of right and left selective samples. Results: The proportion of AVS classified as unsuccessful was almost five times higher with the strictest criteria than with the least strict (18 vs 4%). The proportion of AVS classified as lateralised was more than twice higher with the least stringent criteria than with the most stringent (60 vs 26%). Multiple samples where available from at least one side in 147 AVS. Patients with more than one selective sample were classified differently with the two most extreme samples combinations in 16% (Brisbane) to 18% (Padua) of cases (Fisher’s P=0.75). Conclusion: Different sets of criteria currently used in experienced institutions translate into extremely heterogeneous classifications, and hence surgical decisions, for PA patients. AVS cannot be regarded as a gold standard until the most appropriate procedure and diagnostic criteria have been defined. Large and well-designed studies, preferably multicentre, are needed to resolve this issue.
- 1 April 2014
- Published by Elsevier in La Presse Médicale
- Vol. 43 (4) , 420-427
Hypertension artérielle d’origine surrénale : reconnaître, évaluer et prendre en charge
- 1 April 2014
- Published by Elsevier in La Presse Médicale
- Vol. 43 (4) , 420-427
Hypertension artérielle d’origine surrénale : reconnaître, évaluer et prendre en charge
- Open Access
- 1 April 2014
- Published by Elsevier in La Revue de Médecine Interne
- Vol. 35 (4) , 235-242
Prise en charge actuelle de l’hypertension artérielle
- 1 April 2014
- Published by Elsevier in La Revue de Médecine Interne
- Vol. 35 (4) , 235-242
Open AccessPrise en charge actuelle de l’hypertension artérielle
- 1 May 2013
- Vol. 63 (5) , 684-5
[Medico social management of severe hypertension].